Monkeypox: కేంద్రం కీలక నిర్ణయం.. వ్యాక్సిన్ అభివృద్ధికి టెండర్ల ఆహ్వానం


Join whatsapp group Join Now
Join Telegram group Join Now

Monkeypox: Center's key decision.. Invitation of tenders for vaccine development

Monkeypox Cases In India: Monkeypox cases are increasing all over the world. More than 18 thousand cases have already been registered in 78 countries. Meanwhile, four cases have come to light in India as well. Along with three people from Kerala, one person was infected with monkeypox in Delhi. All of them are currently in isolation and undergoing treatment. Meanwhile, the monkeypox virus was isolated for the first time in the country by the Indian Council of Medical Research-National Institute of Virology in Pune. This research has led to rapid development of diagnostic kits and vaccines.

Recently, the central government has taken a key decision to develop vaccines and diagnostic kits against monkeypox. Tenders have been invited for the manufacture of vaccines. This was revealed by a senior official of the Union Health Ministry. Recently ICMR-NIV Pune has isolated monkeypox virus from patient samples and cultured it. Officials revealed that it matched 99.85 percent with the West African race.

Read Also: Cheating Bridegrooms: One is 13, the other is 5

Currently, the Indian government is also vigilant about monkeypox. Monkeypox has already issued guidelines. Apart from this, 15 labs have been set up for monkeypox diagnosis. Currently, the central government has waved the green flag for the preparation of vaccination. Monkeypox usually subsides within two to four weeks. But experts say that in some cases it can become fatal. Monkeypox cases have a mortality rate of 3-6 percent. People who have close contact with an infected person are more likely to get the disease.



Source link

Leave a Comment